Loomis, Sayles & Company’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-974,719
| Closed | -$32.6M | – | 812 |
|
|
2019
Q4 | $32.6M | Sell |
974,719
-3,208
| -0.3% | -$107K | 0.06% | 137 |
|
|
2019
Q3 | $20.5M | Buy |
977,927
+240,301
| +33% | +$5.03M | 0.04% | 205 |
|
|
2019
Q2 | $15.4M | Buy |
737,626
+170,692
| +30% | +$3.55M | 0.03% | 256 |
|
|
2019
Q1 | $12.7M | Sell |
566,934
-30,525
| -5% | -$682K | 0.02% | 305 |
|
|
2018
Q4 | $14.3M | Buy |
597,459
+115,263
| +24% | +$2.76M | 0.03% | 231 |
|
|
2018
Q3 | $13.2M | Sell |
482,196
-5,076
| -1% | -$138K | 0.03% | 316 |
|
|
2018
Q2 | $13.1M | Buy |
487,272
+33,952
| +7% | +$913K | 0.03% | 352 |
|
|
2018
Q1 | $14.4M | Buy |
+453,320
| New | +$14.4M | 0.03% | 332 |
|